Concentra rebounds from Jounce buy with a shot at COVID-19-focused Atea

cafead

Administrator
Staff member
  • cafead   May 22, 2023 at 10:12: PM
via Weeks after closing a deal to buy Jounce Therapeutics, Concentra Biosciences is rebounding to pick up another struggling biotech, this time COVID-19-focused Atea Pharmaceuticals.

article source